ResMed, Inc. (RMD) Misses Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $228.44 -0.67%
Financial Fact:
Cost of sales: 196.27M
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
Cost of sales: 196.27M
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
ResMed, Inc. (NYSE: RMD) reported Q3 EPS of $0.63, $0.01 worse than the analyst estimate of $0.64. Revenue for the quarter came in at $397.8 million versus the consensus estimate of $401 million.
For earnings history and earnings-related data on ResMed, Inc. (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Etsy upgraded to buy at BofA on durable growth, buyback potential
- Largo restructures $82.2M in debt, extending maturity to 2030
- Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
